Bristol-Myers Squibb Company
BMYUpdated . Prices are snapshots and may be delayed.
Bristol-Myers Squibb Company price chart
AI Outlook for Bristol-Myers Squibb Company
Neutral posture- Long-term trend-1.4% vs 200-day average
- Medium-term trend-7.2% vs 50-day average
- Averages50-day above 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Bristol-Myers Squibb Company performance
About Bristol-Myers Squibb Company
Bristol-Myers Squibb Company is a pharmaceuticals company based in the United States, listed on NEW YORK STOCK EXCHANGE, INC. since 1980 (ticker BMY).
The shares trade at a price-to-earnings ratio of 12.9. The dividend yield is 4.58%.
Bristol-Myers Squibb Company market data
What is the price of Bristol-Myers Squibb Company today?
Bristol-Myers Squibb Company (BMY) is at $59.75, −2.21% on the day.
What is the 52-week range of Bristol-Myers Squibb Company?
Over the past year Bristol-Myers Squibb Company has traded between $42.52 and $68.64. It is currently 66% of the way up that range.
What is the P/E ratio of Bristol-Myers Squibb Company?
Bristol-Myers Squibb Company trades at a price-to-earnings ratio of 12.9.
Similar stocks
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.